‘Antimicrobial resistance is a ticking time bomb not only for the UK but also for the world,’ she says. ‘We need to work with everyone to ensure the apocalyptic scenario of widespread antimicrobial resistance does not become a reality. This is a threat arguably as important as climate change.’
Bomb expert & journalist Jeff Stein not to be confused with CEO of Trius Jeff Stein who said yesterday "Trius is partnering with some terrific companies to bring its drugs to market around the globe. He said the focus will be on both development and commercialization going forward."
The former only states his concerns, the later has a product that works and is doing something about bringing it to market.
He describes the problem of developing new antibiotics as ‘a beast’, adding that ‘the low-hanging fruit in antibiotic drug discovery has almost certainly been harvested by now. We're short of understanding more than anything else. Money for basic research into bacterial targets and bacterial membrane penetration or efflux might be well spent, if we're going to talk financial incentives.’